Skip to content
BDH Industries logo

BDH Industries

524828 BSE
Price unavailable

BDH Industries (BDH) share price was ₹414.95 at the 28 Oct 2026 close; market capitalisation ₹239 Cr; P/E (TTM) 20.41; sector Healthcare. The share price fell 4.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 20.2% year on year to ₹22.38 Cr and net profit rose 48.6% year on year to ₹2.72 Cr (compared with Jun 2025). Promoters held 49.70% of BDH Industries in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 62/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹414.95 +0.55 +0.13% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹239 Cr
P/E (TTM)
20.41
EBITDA
₹16.10 Cr
Return on Equity
14.04%
Debt to Equity
0.03
Book Value
₹131.42
EPS (TTM)
₹20.33
52W High
₹610.00
52W Low
₹340.15

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,767.6035.064,24,106 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,659.0087.672,56,416 Cr15.300.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.6072.361,75,334 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.10108.061,18,172 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.0026.281,17,805 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.4034.661,11,714 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,362.2032.641,10,046 Cr3.110.96%11.21%14.88%28,589 Cr3,356 Cr
BDH Industries (this company)
—20.41239 Cr3.161.19%14.04%19.28%102 Cr12 Cr
Median 8 companies₹1,767.6034.861,17,988 Cr4.710.72%13.92%18.45%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

62 Good
Overall score

Data confidence 98/100

Category scores

Quality Good 61
Returns, margins, earnings quality 22% weight
Valuation Average 53
Cheap vs sector & own history 24% weight
Growth Strong 90
Sales & profit trajectory 9% weight
Financial Health Strong 83
Solvency, leverage, coverage 9% weight
Momentum Good 57
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 27.0%

Weaknesses

1
  • The company has delivered a poor sales growth of 10.8% over past five years.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
43.78% higher than 3Y

change over 1 year

Net Income Growth
16.13% higher than 3Y

change over 1 year

Cash Flow Change
-116%

change over 1 year

EBITDA Margin Change
-16.52%

change over 1 year Operating margin 15.46% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
18.31
19.35
21.06
27.11
16.26
16.23
16.2
17.82
18.62
18.96
29.34
29.03
22.38
Expenses
16.35
16.18
17.57
23.3
14.3
13.18
12.67
14.75
16.5
15.63
25.11
24.82
18.92
Operating Profit
1.96
3.17
3.49
3.81
1.96
3.05
3.53
3.07
2.12
3.33
4.23
4.21
3.46
OPM %
10.7%
16.38%
16.57%
14.05%
12.05%
18.79%
21.79%
17.23%
11.39%
17.56%
14.42%
14.5%
15.46%
Other Income
0.37
0.41
0.37
0.43
0.38
0.43
0.46
0.57
0.55
0.55
0.53
0.61
0.45
Interest
0.04
0.03
0.02
0.1
0.02
0.04
0.01
0.01
0.01
0.03
0.01
0.01
0.01
Depreciation
0.13
0.13
0.13
0.18
0.22
0.23
0.23
0.23
0.22
0.22
0.22
0.22
0.21
PBT
2.16
3.42
3.71
3.96
2.1
3.21
3.75
3.4
2.44
3.63
4.53
4.59
3.69
Tax %
25%
26.61%
25.07%
25.25%
25.24%
25.23%
25.07%
26.76%
25%
27.82%
22.96%
37.25%
26.29%
Net Profit
1.62
2.51
2.78
2.96
1.57
2.41
2.81
2.49
1.83
2.62
3.49
2.88
2.72
EPS (₹)
2.81
4.36
4.83
5.14
2.73
4.19
4.88
4.32
3.18
4.55
6.06
5
4.72
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
44
46
43
41
52
59
57
69
74
86
67
96
100
Expenses
40
42
38
36
45
51
49
60
64
73
55
82
84
Operating Profit
4
4
5
5
7
9
9
9
11
12
12
14
15
OPM %
9%
9%
11%
13%
14%
15%
15%
13%
15%
14%
17%
14%
15%
Other Income
1
2
1
1
1
1
1
1
1
2
2
2
2
Interest
0
0
0
0
1
1
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
PBT
4
5
5
5
7
8
9
10
11
13
12
15
16
Tax %
32%
33%
33%
27%
26%
27%
27%
24%
26%
25%
26%
29%
—
Net Profit
3
3
3
4
5
6
6
7
8
10
9
11
12
EPS (₹)
4.46
5.61
5.8
6.53
8.39
10.32
11.05
12.54
14.24
17.14
16.1
18.78
20.33
Div. Payout %
39%
37%
36%
36%
34%
25%
28%
29%
28%
26%
28%
27%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6
6
6
6
6
6
6
6
6
6
6
6
Reserves
18
21
23
25
28
32
37
43
49
56
63
71
Borrowings
9
9
8
8
13
9
9
2
5
9
1
2
Other Liabilities
19
15
17
18
18
18
19
18
20
23
17
20
Total Liabilities
52
52
54
57
66
65
71
69
80
93
87
99
Fixed Assets
13
13
23
23
22
21
20
20
19
20
20
19
CWIP
0
4
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
38
35
31
34
44
44
51
49
61
73
67
80
Total Assets
52
52
54
57
66
65
71
69
80
93
87
99
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
6
4
7
0
-4
11
1
3
6
-2
15
-2
Investing
0
-5
-5
0
1
1
1
1
0
0
2
2
Financing
-3
-1
-3
-3
3
-6
-2
-8
0
1
-10
-2
Net Cash Flow
3
-1
-1
-2
0
6
0
-4
7
-1
6
-2
Free Cash Flow
6
0
1
-1
-4
11
1
4
6
-4
15
-2
CFO/OP
198
146
186
21
-24
153
35
64
82
11
153
8
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
81
64
67
63
89
68
96
76
82
121
78
120
Inventory Days
71
61
39
95
89
51
53
50
53
30
65
28
Days Payable
201
162
192
244
188
158
171
123
139
128
134
91
Cash Conversion Cycle
-49
-37
-85
-85
-10
-39
-21
4
-5
23
9
58
Working Capital Days
-76
-72
-90
-60
-29
-31
6
56
49
71
102
116
ROCE %
13%
15%
14%
14%
16%
19%
18%
18%
20%
21%
18%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view BDH Industries insights

67 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

FIIs0.28%Promot.49.70%Others20.41%Public29.62%As ofSep 2026

Documents

1
Concall - Nov 2025 Nov 2025
2
Concall - Aug 2025 Aug 2025
3
Concall - Nov 2024 Nov 2024
4
Concall - May 2024 May 2024
5
Concall - Nov 2023 Nov 2023

Frequently Asked Questions about BDH Industries

What does BDH Industries Ltd do?
Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]
Where is BDH Industries Ltd (BDH) listed?
BDH Industries Ltd trades under code 524828 on the BSE.
Which sector does BDH Industries Ltd belong to?
BDH Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of BDH Industries Ltd?
BDH Industries Ltd has a market capitalisation of ₹238.97 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of BDH Industries Ltd?
BDH Industries Ltd trades at a PE ratio of 20.41 as of 28 Oct 2026, on earnings per share of ₹20.33, against a book value of ₹131.42 per share.
What is the 52-week high and low of BDH Industries Ltd?
Over the last 52 weeks BDH Industries Ltd has traded between ₹340.15 and ₹610 as of 28 Oct 2026.
Does BDH Industries Ltd pay dividends?
BDH Industries Ltd has a dividend yield of 1.20%.
What is the Return on Equity (ROE) of BDH Industries Ltd?
BDH Industries Ltd reported a return on equity of 14.04%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]

Website bdhind.com
Listed 1995-04-24
Face Value ₹ 10
Shares Outstanding 57,58,992

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524828.md for BDH Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month